儿童肥厚型心肌病运动试验异常与心脏性猝死及无移植生存的关联
该国际多中心队列研究纳入724例18岁前诊断的原发性肥厚型心肌病患儿,其中630例至少完成一次运动试验,28%结果异常。运动试验异常独立关联较低的5年无移植生存率(97%对88%,P=0.005),运动诱发缺血还独立关联心脏性猝死事件,支持儿童肥厚型心肌病常规运动试验评估。
要点
- 儿童肥厚型心肌病运动试验异常常见,本队列中占28%。
- 运动试验异常独立关联较低5年无移植生存率(97%对88%)。
- 运动诱发缺血独立关联心脏性猝死事件(HR 3.32)。
核心结论
- 儿童肥厚型心肌病运动试验异常独立关联较低无移植生存率,尤其运动诱发缺血或血压反应异常者。
- 运动诱发缺血还独立关联心脏性猝死事件,支持常规运动试验用于持续风险评估。
研究设计与样本
- 国际多中心队列研究,纳入20个中心、诊断时<18岁的表型阳性原发性肥厚型心肌病患者。
- 724例 eligible 患者中630例至少接受1次运动试验,中位运动试验年龄13.8岁(四分位距4.7岁)。
主要发现
- 175例(28%)运动试验结果异常。
- 异常组相比正常组有更严重室间隔肥厚、更高左房内径z评分、更高静息左室流出道压差及更高心肌切除频率(P<0.05)。
- 异常运动试验独立关联较低5年无移植生存率(97%对88%,P=0.005)。
- 运动诱发缺血者全因死亡或移植风险最高(HR 4.86,95%CI 1.69-13.99),其次为血压反应异常者(HR 3.19,95%CI 1.32-7.71)。
- 运动诱发缺血独立关联较低无心脏性猝死事件生存率(HR 3.32,95%CI 1.27-8.70);运动诱发异位搏动与生存无关。
关键数值与推荐
- 运动试验异常定义为血压反应迟钝和/或新发或加重的ST-T段改变或复杂室性异位搏动。
- 心脏性猝死事件定义为心脏性猝死与成功复苏的心脏骤停复合终点。
临床怎么用
- 儿童肥厚型心肌病应将常规运动试验作为持续风险评估的一部分。
- 运动试验异常,尤其运动诱发缺血或血压反应异常,提示需加强无移植生存与猝死风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypertrophic cardiomyopathy (HCM) can be associated with an abnormal exercise response. In adults with HCM, abnormal results on exercise stress testing are predictive of heart failure outcomes. Our goal was to determine whether an abnormal exercise response is associated with adverse outcomes in pediatric patients with HCM. METHODS: In an international cohort study including 20 centers, phenotype-positive patients with primary HCM who were <18 years of age at diagnosis were included. Abnormal exercise response was defined as a blunted blood pressure response and new or worsened ST- or T-wave segment changes or complex ventricular ectopy. Sudden cardiac death (SCD) events were defined as a composite of SCD and aborted sudden cardiac arrest. Using Kaplan-Meier survival, competing outcomes, and Cox regression analyses, we analyzed the association of abnormal exercise test results with transplant and SCD event-free survival. RESULTS: Of 724 eligible patients, 630 underwent at least 1 exercise test. There were no major differences in clinical characteristics between those with or without an exercise test. The median age at exercise testing was 13.8 years (interquartile range, 4.7 years); 78% were male and 39% were receiving beta-blockers. A total of 175 (28%) had abnormal test results. Patients with abnormal test results had more severe septal hypertrophy, higher left atrial diameter z scores, higher resting left ventricular outflow tract gradient, and higher frequency of myectomy compared with participants with normal test results (P<0.05). Compared with normal test results, abnormal test results were independently associated with lower 5-year transplant-free survival (97% versus 88%, respectively; P=0.005). Patients with exercise-induced ischemia were most likely to experience all-cause death or transplant (hazard ratio, 4.86 [95% CI, 1.69-13.99]), followed by those with an abnormal blood pressure response (hazard ratio, 3.19 [95% CI, 1.32-7.71]). Exercise-induced ischemia was also independently associated with lower SCD event-free survival (hazard ratio, 3.32 [95% CI, 1.27-8.70]). Exercise-induced ectopy was not associated with survival. CONCLUSIONS: Exercise abnormalities are common in childhood HCM. An abnormal exercise test result was independently associated with lower transplant-free survival, especially in those with an ischemic or abnormal blood pressure response with exercise. Exercise-induced ischemia was also independently associated with SCD events. These findings argue for routine exercise testing in childhood HCM as part of ongoing risk assessment.
引用
- Conway J, Min S, Villa C, et al. The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy. Circulation. 2022. PMID: 36335467. doi:10.1161/CIRCULATIONAHA.122.062699
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。